On Nov. 12, 2026, The U.S. Department of Agriculture is reporting 128 confirmed cases of New World Screwworm….
On Nov. 12, 2026, Eli Lilly announced it has received regulatory approval in China for its oral glucagon-like…
On Nov. 11, 2026, Novo announced it has committed USD $200 million to the World Diabetes Foundation (WDF)…
On Nov. 8, 2026, a Life Science Genealogy poster spotlighting University of California, Berkeley spin-off companies was published…
On Nov. 7, 2026, a Life Science Genealogy poster that illustrates spin-off companies from Washington’s Universities and Non-Profit…
On Nov. 6, 2026, a Life Science Genealogy poster spotlighting University of Washington spin-off companies was published by…
On Nov. 5, 2026, the University of Texas MD Anderson Cancer Center announced the historic expansion of its…
On Nov. 4, 2026, the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to…
On Nov. 3, 2026, Bioengineered retracted 119 papers in October amid investigations into suspected paper mill activity and…
On Nov. 2, 2026, the U.S. Food and Drug Administration (FDA) published guidance recommendations for developing a science-…
On Nov. 2, 2026, Dr. Reddy’s Laboratories announced that the U.S. Food and Drug Administration (FDA) has granted…
On Oct. 30, 2026, a patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker…
On Oct. 27, 2026, the University of Texas at Austin introduced UT Dell Medicine, its academic health system,…
On Oct. 27, 2026, Anthropic announced the acquisition of Mithril Medicine, a one-person company that has been developing…
On Oct. 23, 2026, the U.S. Food and Drug Administration announced it has approved Awiqli (insulin icodec-abae) injection,…
On Oct. 23, 2026, the U.S. Disease Control and Prevention (CDC) reports that 4,811 patients were admitted to…
On Oct. 22, 2026, Eli Lilly broke ground on a new $5 billion manufacturing facility just west of…
On Oct. 22, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire an…
On Oct. 20, 2026, GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen)…
On Oct. 20, 2026, the University of Notre Dame announced it is investing $275 million in assembling new…
On Oct. 20, 2026, OpenAI announced it has acquired Orchestra Bio, a platform that helps biopharma teams coordinate…
On Oct. 19, 2026, Merck announced it it has entered into a definitive agreement to acquire Silence Therapeutics,…
On Oct. 19, 2026, a Johns Hopkins University scientist whose award-winning work suggests that a brief stomach bug…
On Oct. 19, 2026, The Medical College of Wisconsin (MCW) announced a historic $50 million gift from Linda…
On Oct. 14, 2026, this fall, the Massachusetts Institute of Technology, where 95% of students are STEM majors,…
On Oct. 9, 2026, current and former local and statewide officials joined staff from the pharmaceuticals company Tonix…
On Oct. 9, 2026, Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved WELTRUZA™ (olanzapine)…
On Oct. 9, 2026, the U.S. Food and Drug Administration (FDA) has approved Asahi Kasei Therapeutics’ Hovilpri (pritelivir)…
On Oct. 8, 2026, Viatris, a global healthcare company, and Pacira BioSciences, a leader in innovative non-opioid pain…
On Oct. 7, 2026, Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding…